Also relevant, compounders are being sued by Eli Lilly right now. The compounding loophole is being welded shut:

https://glp1.guide/content/eli-lilly-suing-glp1-compounders-...

Only a partial patent expiry for Semaglutide in 2026, then full in 2033:

https://glp1.guide/content/patent-expirations-for-glp1-recep...